John F. Collins

TL;DR: In this article, the authors examined whether the timing of the initiation of maintenance dialysis influenced survival among patients with chronic kidney disease and found no significant difference between the groups in the frequency of adverse events, infections, or complications of dialysis.

TL;DR: Obesity at the commencement of renal replacement therapy is a significant risk factor for death and technique failure in patients treated with peritoneal dialysis and should be considered for early transfer to an alternative renal replacement Therapy if difficulties are experienced.

TL;DR: Change in albuminuria was consistently associated with subsequent risk of end-stage kidney disease across a range of cohorts, lending support to the use of change inalbuminuria as a surrogate endpoint for end-Stage kidney disease in clinical trials of progression of chronic kidneys disease in the setting of increased album inuria.

TL;DR: Higher BMI at the commencement of renal replacement therapy is a significant risk factor for peritonitis, andCoronary artery disease and chronic lung disease were associated with both shorter time to firstperitonitis and higher peritoneitis rates, independently of these other factors.

TL;DR: The diversity of peritoneal transport characteristics in different ethnic populations suggests that additional validation of PET measurements in various racial groups and study of their relationship to patient outcomes are warranted.